Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 3, 2006, Pages 321-322

  Van Biervliet, S ^a   Raes, A ^a   Vande Walle, J ^a   Van Winckel, M ^a   Robberecht, E ^a   Praet, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Inflammatory bowel disease; Interstitial nephritis; Mesalazine

Indexed keywords

ANTIBIOTIC AGENT; MESALAZINE; PREDNISOLONE;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; NEPHROTOXICITY; PYELONEPHRITIS; SCHOOL CHILD; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; MESALAMINE; PREDNISOLONE; PYELONEPHRITIS;

EID: 33751315104     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. FOCKENS P., MULDER C.J.J., TYTGAT G.N.J., BLOK P., FERWERDA J. AND THE DUTCH PENTASA STUDY GROUP. Comparison of efficacy and safety of 1.5 vs 3.0 g oral slow-release mesalazine (pentasa) in the maintenance treatment of ulcerative colitis. Eur. J. Gastroenterol. Hepatol., 1995, 7: 1025-30.
2. WORLD M.J., STEVENS P.E., ASHTON M.A., RAINFORD D.J. Mesalazine- associated interstitial nephritis. Nephrol. Dial. Transplant., 1996, 11: 614-21.
3. FRANDSEN N.E., SAUGMANN S., MARCUSSEN N. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Nephron. 2002, 92: 200-2.
4. VAN STAA T.P., TRVIS S., LEUFKENS H.G.M., LOGAN R.F. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study. Gastroenterology, 2004, 126: 1733-9.
5. CORRIGAN G., STEVENS P.E. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol. Ther., 2000, 14: 1-6.
6. MEHTA R.P. Acute interstitial nephritis due to 5-aminosalicylic acid. Can. Med. Assoc. J., 1990, 143: 1031-2.
7. THULUVATH P.J., NINKOVIC M., CALAM J., ANDERSON M. Mesalazine induced interstitial nephritis. Gut. 1994, 35: 1493-6.
8. WITTE T., OLBRICHT C.J., KOCH K.M. Interstitial nephritis associated with 5-aminosalicylic acid. Nephron. 1994, 481-2.
9. MANENTI L., DEROSA A., BUZIO C. Mesalazine associated interstitial nephritis twice in the same patient. Nephrol. Dial. Transplant., 1997, 12: 2031.
10. HÄMLING J., RAEDLER A., HELMCHEN U., SCHREIBER S. 5-aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion. 1997, 58: 304-7.
11. POPOOLA J., MULLER A.F., POLLOCK L., O'DONNELL P., CARMICHAEL P., STEVENS P. Late onset interstitial nephritis associated with mesalazine treatment. BMJ, 1998, 317: 795-7.
12. HAAS M., SHETYE K.R. Acute renal failure in a 53-year-old Woman with crohn's disease treated with 5-Aminosalicylic acid. Am. J. Kidney Dis., 2001, 1: 205-9.
13. AREND L.J., SPRINGATE J.E. Interstitial nephritis from mesalazine: case report and literature review. Pediatr. Nephrol., 2004, 19: 550-3.
14. BENADOR N., GRIMM P., LEMIRE J., GRISWOLD W., BILLMAN G., REZNIK V. Interstitial nephritis in children with Crohn's disease. Clinical Pediatrics, 2000, 39: 253-4.
15. SAWCZENKO A., SANDHU B.K., LOGAN R.F., JENKINS H., TAYLOR G., MIAN S., LYNN R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet, 2001, 7: 1093-4.
16. WALKER-SMITH J., MURCH S. Crohn's disease and abdominal tuberculosis. In: WALKER-SMITH J., MURCH S. (eds). Diseases of the small intestine in childhood. Oxford: ISIS Medical media: fourth edition, 1999, 299-328.
17. RANSFORD R.A.J., LANGMAN M.J.S. Sulphalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut, 2002, 51: 536-39.